SEC Form 4 · accession 0001445866-17-001279
IRIDEX CORP · IRIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 28, 2017 | J | 54,195 | $0.00 | D | 1,406,493 | D |
Table II — derivative securities
Explanation of responses
- F1These securities were owned by BlueLine Capital Partners, L.P. On August 28, 2017, BlueLine Capital Partners, L.P. executed an in-kind distribution, without consideration, of 54,195 shares of the Issuer's common stock to certain of its limited partners.
Remarks
Scott A. Shuda, by power of attorney for all reporting persons. As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities.